Major Milestone Unlocked: Saints Sages products are officially available in Australia!

Recently, Saints Sages achieved a major milestone: the SA100 Radiofrequency and UItrasonic Surgical System, SA10 Portable Ultrasonic Controller, and SP10 Portable Advanced Bipolar Generator have officially received registration approval from the Therapeutic Goods Administration (TGA) of Australia! This marks the official entry of Saints Sages next-generation energy surgical instruments into the Australian market, bringing higher precision, safer, and more efficient surgical solutions to local hospitals.

• SA100: 

As a world-first dual-channel energy platform, the SA100 simultaneously integrates ultrasonic and advanced bipolar modules, allowing seamless switching between energy modes during surgery without the need to repeatedly swap handpieces. Equipped with RTTE II Real-Time Tissue Adaptive technology and MPTS Multi-Pulse Tissue Sensing technology, it is clinically proven to reliably seal large blood vessels up to 7 mm. It is widely applicable across multiple specialties, including gastrointestinal, gynecological, hepatobiliary/pancreatic, and thoracic surgeries.

• SA10: 

As a world-first portable controller, the SA10 is the size of a smartphone, weighs just 0.6 kg, and offers plug-and-play convenience. This series innovatively integrates the ultrasonic shear and transducer into a single unit—eliminating transducer wear, repeated sterilization, and pre-operative assembly to streamline clinical operations. Powered by the RTTE II smart algorithm, which performs 50,000 calculations per second to precisely regulate energy, the SA10 ensures safe vessel sealing up to 7 mm while significantly enhancing cutting efficiency and procedural smoothness.

• SP10: 

As a world-first portable advanced bipolar generator, the palm-sized SP10 houses a powerful energy core and the MPTS AI algorithm. It adapts to different tissue types to reliably seal large blood vessels up to 7 mm while effectively reducing surgical smoke and tissue adhesion, empowering a safer, more efficient surgical workflow across diverse clinical scenarios.

This TGA approval represents another key milestone in Saints Sages global development strategy, adding to certifications from NMPA, CE-MDR, FDA, and approvals in over 20 countries and regions. Moving from "Smart Manufacturing in China" to serving the world, Saints Sages leverages its solid technological foundation to provide global surgeons with more reliable and intelligent energy surgical solutions—showcasing the strength of continuous innovation in the field of energy surgery.